Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor

Obstetrics and Gynecology

Volumn 110, Issue 2 II, 2007, Pages 518-520

  Hardman, Mary Pat ^a   Roman, Juan J ^a   Burnett, Alexander F ^a   Santin, Alessandro D ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ESTROGEN RECEPTOR; PLATINUM; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AROMATASE INHIBITOR; NITRILE; TRIAZOLE DERIVATIVE;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER REGRESSION; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LUNG NODULE; METASTASIS; PREGNANCY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUMOR REGRESSION; UTERUS LEIOMYOSARCOMA; HYSTERECTOMY; LUNG TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; REMISSION; UTERUS CANCER;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AROMATASE INHIBITORS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LUNG NEOPLASMS; MIDDLE AGED; NITRILES; REMISSION INDUCTION; TREATMENT OUTCOME; TRIAZOLES; UTERINE NEOPLASMS;

EID: 34548462063     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000267533.56546.c2     Document Type: Article

References (8)

1. DiSaia PJ, Creasman WT. Cervical cancer. In: DiSaia PJ, Creasman WT, editors. Clinical gynecologic oncology. 5th ed. St. Louis (MO): Mosby; 1997. p. 1-106.
2. Look KY, Sandler A, Blessing JA, Lucci JA, Rose PG. Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) study, Gynecol Oncol 2004;92:644-7.
3. Omura GA, Major FJ, Blessing JA, Sedlacek TV, Thigpen JT, Creasman WT, et al. A randomized study of Adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 1983;52:626-32.
4. Hensley ML, Maki R, Venkatraman E, Geller G, Lovegren M, Aghajanian C, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 2002;20:2824-31.
5. Ryan PD, Goss PE. Adjuvant hormonal therapy in peri- and postmenopausal breast cancer. Oncologist 2006;11:718-31.
6. Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Leodolter S, Mayerhofer K. Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters. Anticancer Res 2003;23:729-32.
7. Rao UN, Finkelstein SD, Jones MW. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas. Mod Pathol 1999;12:1001-9.
8. Shozu M, Murakami K, Segawa T, Kasai T, Inoue M. Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor. Fertil Steril 2003;79:628-31.